Only Eluvia uses a polymer for controlled, targeted delivery of the lowest drug dose

polymer image

Through its polymer-based drug delivery, Eluvia transfers the majority of the drug to the tissue and minimizes downstream particulates.

2-year TLR data
comparable all-cause mortality rates
Coronary polymer-based paclitaxel-eluting stents have demonstrated similar all-cause mortality compared to bare metal stents at 5 years.
 
Patients treated with Eluvia showed a similar all-cause mortality rate compared to PAD patients analyzed in a large population based study.
2-year All Cause Mortality chart
1. Amputation Rates, Mortality, and Pre-operative Comorbidities in Patients Revascularised for Intermittent Claudication or Critical Limb Ischaemia: A Population Based Study Baubeta Fridh, E. et al. European Journal of Vascular and Endovascular Surgery, Volume 54, Issue 4, 480 – 486.
 

New Eluvia 2-year TLR data show very low revascularization rates with polymer-based delivery.

2-year TLR data
TLR rate 2-years

 

 

 

 

 

 

 

As a polymer-based drug eluting stent, Eluvia is more like coronary stents, such as Boston Scientific's TAXUS, versus peripheral paclitaxel-coated products. Both Eluvia and TAXUS deliver the same drug and are similar in design intent and mechanism of action; both yielding sustained, targeted paclitaxel delivery.

  •  In the MAJESTIC Clinical Trial, Eluvia demonstrated a 3.6% all-cause mortality rate at 3 years, which is in line or lower than with non-coated devices*
  • As published in JACC:CI, TAXUS demonstrated a 9.8% all-cause mortality rate at 5 years, compared to 9.1% in the BMS arm (p-value = 0.53)

 

* Innova Bare Metal Stent (SuperNOVA Trial) 3-year All-Cause Mortality: 7.9%

image

A 5-year patient-level pooled meta analysis

from randomized, controlled trials, published in JACC:CI, from 2,797 patients (TAXUS DES vs. BMS) showed no difference in mortality

5 year data in PAD patients

(TAXUS DES vs PTA + BMS) showed no difference in mortality in CLI

image

 

 

Sign Up Today

Stay Up to Date

Receive emails about the latest drug-eluting technology news, innovations and events in your area.

Explore Resources

Explore DE Resources

Get physician perspectives, clinical data sheets and other resources about drug-eluting innovations.

Top